Ischemic and bleeding risk after an acute coronary syndrome in patients with prior history of cancer treated with dual antiplatelet therapy

被引：0
|
作者：
Munoz Pousa, I. [1 ]
Raposeiras Roubin, S. [1 ]
Abu-Assi, E. [1 ]
Manzano Fernandez, S. [2 ]
D'Ascenzo, F. [3 ]
Henriques, P. J. Simao [4 ]
Saucedo, J. [5 ]
Ariza Sole, A. [6 ]
Cambronero Sanchez, F. [7 ]
Flores Blanco, P. J. [2 ]
Cespon Fernandez, M. [1 ]
Caneiro Queija, B. [1 ]
Cobas Paz, R. [1 ]
Iniguez Romo, A. [1 ]
机构：
[1] Hosp Univ Alvaro Cunqueiro, Cardiol, Vigo, Spain
[2] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[3] Univ Turin, Turin, Italy
[4] Acad Med Ctr Amsterdam, Amsterdam, Netherlands
[5] NorthShore Univ Hosp, Chicago, IL USA
[6] Univ Hosp Bellvitge, Barcelona, Spain
[7] Hosp Gen Univ Los Arcos del Mar Menor, Murcia, Spain
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P672
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [31] ATTAIN: dual antiplatelet therapy in patients presenting with acute coronary syndrome
    Machata, M.
    Egger, F.
    Freynhofer, M.
    Huber, K.
    Weiss, T.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S8 - S8
  • [32] Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome
    Spirito, Alessandro
    Mehran, Roxana
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (01) : 114 - 115
  • [33] Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Wilson, Simon
    Newby, David E.
    HEART, 2017, 103 (15) : 1143 - 1145
  • [34] Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
    Pelliccia, Francesco
    Gragnano, Felice
    Pasceri, Vincenzo
    Cesaro, Arturo
    Zimarino, Marco
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [35] Complications of dual antiplatelet therapy combined with an oral anticoagulation in patients with Acute Coronary Syndrome treated with PCI
    Banaszewski, M.
    Drozdz, J.
    Wozakowska-Kaplon, B.
    Ablewska, U.
    Wojtkowska, I.
    Stepinska, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 666 - 666
  • [36] Incidence of bleeding and performance of the PRECISE-DAPT score in predicting bleeding in patients on dual antiplatelet therapy after treatment for acute coronary syndrome in Kenya
    Mugo, Peter
    Jeilan, Mohamed
    Msunza, Miriam
    Orwa, James
    Ngunga, Mzee
    BMC CARDIOVASCULAR DISORDERS, 2025, 25 (01):
  • [37] Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations
    Cui, Kongyong
    Wu, Shaoyu
    Yin, Dong
    Song, Weihua
    Wang, Hongjian
    Zhu, Chenggang
    Feng, Lei
    Yang, Yuejin
    Fu, Rui
    Dou, Kefei
    CARDIOLOGY JOURNAL, 2024, 31 (01) : 32 - 44
  • [38] Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk
    Mauro, Maria Sara
    Capodanno, Davide
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [39] Impact of renal function on adverse bleeding events associated with dual antiplatelet therapy in patients with acute coronary syndrome
    Toshiharu Fujii
    Kazushige Amano
    Satoshi Kasai
    Yota Kawamura
    Fuminobu Yoshimachi
    Yuji Ikari
    Cardiovascular Intervention and Therapeutics, 2024, 39 : 28 - 33
  • [40] Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Yan, B.
    Lai, A.
    Sun, H.
    Tam, T. K.
    Tan, G. M.
    EUROPEAN HEART JOURNAL, 2023, 44
12345